DOCSLIB.ORG

Supplementary Table S2. List of the Genes Up-Regulated 1-2 Days Following CTX Treatment

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Supplementary Table S2. List of the Genes Up-Regulated 1-2 Days Following CTX Treatment Supplementary Table S2. List of the genes up-regulated 1-2 days following CTX treatment Gene Parametric Description EntrezID symbol p-value* PHPT1 phosphohistidine phosphatase 1 29085 1.20E-06 CDKN1A cyclin-dependent kinase inhibitor 1A (p21, Cip1) 1026 1.20E-06 BBC3 BCL2 binding component 3 27113 4.00E-06 TRIAP1 hypothetical protein HSPC132 51499 6.80E-06 OAS1 2'-5'-oligoadenylate synthetase 1, 40/46kDa 4938 1.80E-05 RXRA retinoid X receptor, alpha 6256 2.16E-05 FCGR1A FCGR1A Fc fragment of IgG, high affinity Ia, receptor (CD64) 2209 2.26E-05 RPS27L ribosomal protein S27-like 51065 2.73E-05 MKNK2 MAP kinase interacting serine/threonine kinase 2 2872 3.32E-05 AKR1A1 aldo-keto reductase family 1, member A1 (aldehyde reductase) 10327 3.33E-05 RPS27L ribosomal protein S27-like 51065 4.90E-05 D15Wsu75e DNA segment, Chr 15, Wayne State University 75, expressed 27351 5.85E-05 IFI30 interferon, gamma-inducible protein 30 10437 8.34E-05 DMD dystrophin (muscular dystrophy, Duchenne and Becker types) 1756 1.07E-04 SAC3D1 Sac3 homology domain 1 (S. cerevisiae) 29901 1.12E-04 ZDHHC3 zinc finger, DHHC domain containing 3 51304 1.21E-04 CALML4 calmodulin-like 4 91860 1.29E-04 NAPRT1 similar to CG3714 gene product 93100 1.56E-04 UBE2L6 ubiquitin-conjugating enzyme E2L 6 9246 1.65E-04 PTPN7 Protein tyrosine phosphatase, non-receptor type 7 5778 1.68E-04 SULT1A3 Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 6818 1.69E-04 PLXNB1 plexin B1 5364 1.88E-04 PLAC8 placenta-specific 8 51316 1.99E-04 CD163L1 scavenger receptor cysteine-rich type 1 protein M160 283316 2.05E-04 BAX BCL2-associated X protein 581 2.07E-04 CLN2 tripeptidyl peptidase I 1200 2.07E-04 RPL14 ribosomal protein L14 9045 2.18E-04 FTLP3 ferritin, light polypeptide pseudogene 3 284764 2.25E-04 RGS19 regulator of G-protein signalling 19 10287 2.40E-04 Q9Y4D0 KIAA0674 23307 2.58E-04 FTL ferritin, light polypeptide 2512 2.60E-04 RNASET2 ribonuclease T2 8635 2.66E-04 ISG20L1 hypothetical protein FLJ12484 64782 2.88E-04 VNN2 vanin 2 8875 2.93E-04 DAPK3 death-associated protein kinase 3 1613 2.94E-04 LILRB2 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM 10288 3.05E-04 domains), member 2 TMEM134 hypothetical protein FLJ21749 80194 3.12E-04 COMT Catechol-O-methyltransferase 1312 3.13E-04 TTYH2 tweety homolog 2 (Drosophila) 94015 3.23E-04 PLA2G4A phospholipase A2, group IVA (cytosolic, calcium-dependent) 5321 3.39E-04 PNKD myofibrillogenesis regulator 1 25953 3.57E-04 PPM1F protein phosphatase 1F (PP2C domain containing) 9647 3.61E-04 NEU1 sialidase 1 (lysosomal sialidase) 4758 3.71E-04 SYK spleen tyrosine kinase 6850 3.79E-04 FDXR Ferredoxin reductase 2232 3.81E-04 GALK1 galactokinase 1 2584 4.15E-04 GSTP1 glutathione S-transferase pi 2950 4.20E-04 UNC93B1 unc-93 homolog B1 (C. elegans) 81622 4.35E-04 BCL6 B-cell CLL/lymphoma 6 (zinc finger protein 51) 604 4.39E-04 MSRB methionine sulfoxide reductase B2 22921 4.63E-04 IBA2 DNA segment on chromosome X (unique) 9879 expressed sequence 8270 4.72E-04 PYCARD PYD and CARD domain containing 29108 4.76E-04 NFKBIA nuclear factor of kappa light polypeptide gene enhancer in B-cells 4792 5.51E-04 inhibitor, alpha SERPINF2 serine (or cysteine) proteinase inhibitor, clade F (alpha-2 antiplasmin, 5345 6.12E-04 pigment epithelium derived factor), member 2 IRF5 interferon regulatory factor 5 3663 6.22E-04 IFITM2 interferon induced transmembrane protein 2 (1-8D) 10581 6.27E-04 CD68 CD68 antigen 968 6.32E-04 MGST2 microsomal glutathione S-transferase 2 4258 6.63E-04 SLC39A1 solute carrier family 39 (zinc transporter), member 1 27173 6.65E-04 C9orf69 chromosome 9 open reading frame 69 90120 6.89E-04 PX19 px19-like protein 27166 6.98E-04 MARCO macrophage receptor with collagenous structure 8685 7.20E-04 MS4A7 membrane-spanning 4-domains, subfamily A, member 7 58475 7.23E-04 GATAD2B transcription repressor p66 beta component of the MeCP1 complex 57459 7.45E-04 GRHPR glyoxylate reductase/hydroxypyruvate reductase 9380 7.83E-04 HN1 hematological and neurological expressed 1 51155 7.94E-04 RRAS related RAS viral (r-ras) oncogene homolog 6237 8.20E-04 ORAI3 hypothetical protein MGC13024 93129 8.22E-04 GLRX glutaredoxin (thioltransferase) 2745 8.28E-04 SCO2 SCO cytochrome oxidase deficient homolog 2 9997 8.39E-04 NPNT NPNT nephronectin 255743 8.53E-04 NICAL NEDD9 interacting protein with calponin homology and LIM domains 64780 8.56E-04 SESN2 sestrin 2 83667 8.67E-04 IFI27 interferon, alpha-inducible protein 27 3429 8.77E-04 DRAM hypothetical protein FLJ11259 55332 8.79E-04 RBMY2EP RNA binding motif protein, Y-linked, family 2, member E pseudogene 159125 8.85E-04 DOCR tumor suppressor deleted in oral cancer-related 1 10263 8.88E-04 POLR2J polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa 5439 8.89E-04 SLC11A1 solute carrier family 11 (proton-coupled divalent metal ion transporters), 6556 9.02E-04 member 1 C19orf39 hypothetical protein FLJ35119 126074 9.20E-04 STX10 syntaxin 10 8677 9.33E-04 ARPC3 actin related protein 2/3 complex, subunit 3, 21kDa 10094 9.33E-04 PHLDA3 pleckstrin homology-like domain, family A, member 3 23612 9.36E-04 H163 HSPC163 protein 29097 9.42E-04 SCARB2 scavenger receptor class B, member 2 950 9.63E-04 LAMP2 lysosomal-associated membrane protein 2 3920 9.78E-04 BATF3 Jun dimerization protein p21SNFT 55509 1.03E-03 FLJ21511 hypothetical protein FLJ21511 80157 1.04E-03 TFEC transcription factor EC 22797 1.06E-03 MAML3 mastermind-like 3 (Drosophila) 55534 1.08E-03 HES4 hairy and enhancer of split 4 (Drosophila) 57801 1.08E-03 GLA galactosidase, alpha 2717 1.16E-03 PGD Phosphogluconate dehydrogenase 5226 1.19E-03 BLVRA biliverdin reductase A 644 1.20E-03 BAX BCL2-associated X protein 581 1.24E-03 RNF31 ring finger protein 31 55072 1.25E-03 PYCARD PYD and CARD domain containing 29108 1.28E-03 IGFBP7 insulin-like growth factor binding protein 7 3490 1.31E-03 SLC17A2 solute carrier family 17 (sodium phosphate), member 2 10246 1.31E-03 NAGK N-acetylglucosamine kinase 55577 1.33E-03 RAB24 RAB24, member RAS oncogene family 53917 1.35E-03 TINF2 TERF1 (TRF1)-interacting nuclear factor 2 26277 1.37E-03 PLCG2 Phospholipase C, gamma 2 (phosphatidylinositol-specific) 5336 1.40E-03 UHRF1 ubiquitin-like, containing PHD and RING finger domains, 1 29128 1.43E-03 CDK11 cell division cycle 2-like 6 (CDK8-like) 23097 1.45E-03 GNA15 Guanine nucleotide binding protein (G protein), alpha 15 (Gq class) 2769 1.46E-03 CAMKK2 calcium/calmodulin-dependent protein kinase kinase 2, beta 10645 1.46E-03 PTCD3 FLJ20758 protein 55037 1.48E-03 SF3B2 splicing factor 3b, subunit 2, 145kDa 10992 1.48E-03 FAM21C KIAA0592 protein 253725 1.49E-03 KYNU kynureninase (L-kynurenine hydrolase) 8942 1.50E-03 C3orf60 nuclear protein E3-3 25915 1.53E-03 G10 maternal G10 transcript 8896 1.54E-03 DDB2 damage-specific DNA binding protein 2, 48kDa 1643 1.55E-03 LILRA3 leukocyte immunoglobulin-like receptor, subfamily A (without TM 11026 1.55E-03 domain), member 3 SIDT2 SID1 transmembrane family, member 2 51092 1.59E-03 ITPRIPL2 hypothetical protein LOC162073 162073 1.59E-03 ROGDI leucine zipper domain protein 79641 1.59E-03 RHOC ras homolog family member C 389 1.61E-03 UBE2R2 ubiquitin-conjugating enzyme E2R 2 54926 1.66E-03 IRF7 interferon regulatory factor 7 3665 1.68E-03 LOC388955 PRELI domain-containing protein 1, mitochondrial pseudogene 388955 1.69E-03 CTSC cathepsin C 1075 1.71E-03 CNKSR1 connector enhancer of kinase suppressor of Ras 1 10256 1.72E-03 NUP43 nucleoporin 43kDa 348995 1.74E-03 HES4 hairy and enhancer of split 4 (Drosophila) 57801 1.81E-03 OSIL sequestosome 1 8878 1.84E-03 GABBR1 Gamma-aminobutyric acid (GABA) B receptor, 1 2550 1.85E-03 ST3GAL4 ST3 beta-galactoside alpha-2,3-sialyltransferase 4 6484 1.86E-03 LOC440525 proline rich 13 pseudogene 440525 1.86E-03 TST thiosulfate sulfurtransferase (rhodanese) 7263 1.91E-03 ASB5 ankyrin repeat and SOCS box-containing 5 140458 1.91E-03 PPARGC1B peroxisome proliferative activated receptor, gamma, coactivator 1, beta 133522 1.96E-03 CISD3 hypothetical protein LOC284106 284106 1.96E-03 JTB jumping translocation breakpoint 10899 2.01E-03 MHC2TA MHC class II transactivator 4261 2.02E-03 MLN motilin 4295 2.02E-03 BZRP benzodiazapine receptor (peripheral) 706 2.07E-03 GPS2 G protein pathway suppressor 2 2874 2.07E-03 Q9P2L8 KIAA1328 57536 2.07E-03 C8orf70 CGI-62 protein 51101 2.10E-03 CCND3 cyclin D3 896 2.12E-03 APG3L APG3 autophagy 3-like (S. cerevisiae) 64422 2.12E-03 LOC400236 Hypothetical LOC400236 400236 2.15E-03 SNRPA small nuclear ribonucleoprotein polypeptide A 6626 2.17E-03 SCYL1 SCY1-like 1 (S. cerevisiae) 57410 2.21E-03 GAA glucosidase, alpha; acid 2548 2.22E-03 C19orf45 FLJ35784 protein 374877 2.22E-03 CD97 CD97 antigen 976 2.23E-03 TYK2 tyrosine kinase 2 7297 2.26E-03 NQO2 NAD(P)H dehydrogenase, quinone 2 4835 2.31E-03 TNFRSF1A tumor necrosis factor receptor superfamily, member 1A 7132 2.31E-03 HDAC5 histone deacetylase 5 10014 2.31E-03 G1P2 interferon, alpha-inducible protein (clone IFI-15K) 9636 2.33E-03 O2B3 olfactory receptor, family 2, subfamily B, member 3 442184 2.39E-03 EMR2 Egf-like module containing, mucin-like, hormone receptor-like 2 30817 2.39E-03 XRCC1 X-ray repair complementing defective repair in Chinese hamster cells 1 7515 2.40E-03 ACK1 tyrosine kinase, non-receptor, 2 10188 2.41E-03 LST1 leukocyte specific transcript 1 7940 2.41E-03 DDB2 damage-specific DNA binding protein 2, 48kDa 1643 2.42E-03 CG96 CGI-96 protein 27341 2.42E-03 LILRB1 leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM 10859 2.50E-03 domains), member 1 C1orf54 hypothetical
Load more

Recommended publications
  • Viewed Under 23 (B) Or 203 (C) fi M M Male Cko Mice, and Largely Unaffected Magni Cation; Scale Bars, 500 M (B) and 50 M (C)
    BRIEF COMMUNICATION www.jasn.org Renal Fanconi Syndrome and Hypophosphatemic Rickets in the Absence of Xenotropic and Polytropic Retroviral Receptor in the Nephron Camille Ansermet,* Matthias B. Moor,* Gabriel Centeno,* Muriel Auberson,* † † ‡ Dorothy Zhang Hu, Roland Baron, Svetlana Nikolaeva,* Barbara Haenzi,* | Natalya Katanaeva,* Ivan Gautschi,* Vladimir Katanaev,*§ Samuel Rotman, Robert Koesters,¶ †† Laurent Schild,* Sylvain Pradervand,** Olivier Bonny,* and Dmitri Firsov* BRIEF COMMUNICATION *Department of Pharmacology and Toxicology and **Genomic Technologies Facility, University of Lausanne, Lausanne, Switzerland; †Department of Oral Medicine, Infection, and Immunity, Harvard School of Dental Medicine, Boston, Massachusetts; ‡Institute of Evolutionary Physiology and Biochemistry, St. Petersburg, Russia; §School of Biomedicine, Far Eastern Federal University, Vladivostok, Russia; |Services of Pathology and ††Nephrology, Department of Medicine, University Hospital of Lausanne, Lausanne, Switzerland; and ¶Université Pierre et Marie Curie, Paris, France ABSTRACT Tight control of extracellular and intracellular inorganic phosphate (Pi) levels is crit- leaves.4 Most recently, Legati et al. have ical to most biochemical and physiologic processes. Urinary Pi is freely filtered at the shown an association between genetic kidney glomerulus and is reabsorbed in the renal tubule by the action of the apical polymorphisms in Xpr1 and primary fa- sodium-dependent phosphate transporters, NaPi-IIa/NaPi-IIc/Pit2. However, the milial brain calcification disorder.5 How- molecular identity of the protein(s) participating in the basolateral Pi efflux remains ever, the role of XPR1 in the maintenance unknown. Evidence has suggested that xenotropic and polytropic retroviral recep- of Pi homeostasis remains unknown. Here, tor 1 (XPR1) might be involved in this process. Here, we show that conditional in- we addressed this issue in mice deficient for activation of Xpr1 in the renal tubule in mice resulted in impaired renal Pi Xpr1 in the nephron.
    [Show full text]
  • Propranolol-Mediated Attenuation of MMP-9 Excretion in Infants with Hemangiomas
    Supplementary Online Content Thaivalappil S, Bauman N, Saieg A, Movius E, Brown KJ, Preciado D. Propranolol-mediated attenuation of MMP-9 excretion in infants with hemangiomas. JAMA Otolaryngol Head Neck Surg. doi:10.1001/jamaoto.2013.4773 eTable. List of All of the Proteins Identified by Proteomics This supplementary material has been provided by the authors to give readers additional information about their work. © 2013 American Medical Association. All rights reserved. Downloaded From: https://jamanetwork.com/ on 10/01/2021 eTable. List of All of the Proteins Identified by Proteomics Protein Name Prop 12 mo/4 Pred 12 mo/4 Δ Prop to Pred mo mo Myeloperoxidase OS=Homo sapiens GN=MPO 26.00 143.00 ‐117.00 Lactotransferrin OS=Homo sapiens GN=LTF 114.00 205.50 ‐91.50 Matrix metalloproteinase‐9 OS=Homo sapiens GN=MMP9 5.00 36.00 ‐31.00 Neutrophil elastase OS=Homo sapiens GN=ELANE 24.00 48.00 ‐24.00 Bleomycin hydrolase OS=Homo sapiens GN=BLMH 3.00 25.00 ‐22.00 CAP7_HUMAN Azurocidin OS=Homo sapiens GN=AZU1 PE=1 SV=3 4.00 26.00 ‐22.00 S10A8_HUMAN Protein S100‐A8 OS=Homo sapiens GN=S100A8 PE=1 14.67 30.50 ‐15.83 SV=1 IL1F9_HUMAN Interleukin‐1 family member 9 OS=Homo sapiens 1.00 15.00 ‐14.00 GN=IL1F9 PE=1 SV=1 MUC5B_HUMAN Mucin‐5B OS=Homo sapiens GN=MUC5B PE=1 SV=3 2.00 14.00 ‐12.00 MUC4_HUMAN Mucin‐4 OS=Homo sapiens GN=MUC4 PE=1 SV=3 1.00 12.00 ‐11.00 HRG_HUMAN Histidine‐rich glycoprotein OS=Homo sapiens GN=HRG 1.00 12.00 ‐11.00 PE=1 SV=1 TKT_HUMAN Transketolase OS=Homo sapiens GN=TKT PE=1 SV=3 17.00 28.00 ‐11.00 CATG_HUMAN Cathepsin G OS=Homo
    [Show full text]
  • PLEKHM2 Mutation Leads to Abnormal Localization of Lysosomes, Impaired
    Human Molecular Genetics, 2015, Vol. 24, No. 25 7227–7240 doi: 10.1093/hmg/ddv423 Advance Access Publication Date: 12 October 2015 Original Article ORIGINAL ARTICLE PLEKHM2 mutation leads to abnormal localization Downloaded from of lysosomes, impaired autophagy flux and associates with recessive dilated cardiomyopathy and left ventricular noncompaction http://hmg.oxfordjournals.org/ Emad Muhammad1,†, Aviva Levitas2,†, Sonia R. Singh3,4, Alex Braiman1, Rivka Ofir5, Sharon Etzion5, Val C. Sheffield6, Yoram Etzion5,7, Lucie Carrier3,4 and Ruti Parvari1,8,* 1Department of Microbiology, Immunology and Genetics, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel, 2Department of Pediatric Cardiology, Soroka University Medical Center and at Bibliothekssystem Universitaet Hamburg on December 2, 2015 Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel, 3Department of Experimental Pharmacology and Toxicology, Cardiovascular Research Center, University Medical Center Hamburg-Eppendorf, Hamburg 20246, Germany, 4DZHK (German Centre for Cardiovascular Research), partner site Hamburg/Kiel/Lübeck, Germany, 5Regenerative Medicine and Stem Cell Research Center, Beer-Sheva 84105, Israel, 6Department of Pediatrics, Division of Medical Genetics and Hughes Medical Institute, University of Iowa, Iowa City, IA 52242, USA, 7Department of Physiology and Cell Biology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel and 8National Institute for Biotechnology in the Negev, Ben- Gurion University of the Negev, Beer-Sheva, Israel *To whom correspondence should be addressed. Tel: +972 86479967; Fax: +972 86472983; Email: [email protected] Abstract Gene mutations, mostly segregating with a dominant mode of inheritance, are important causes of dilated cardiomyopathy (DCM), a disease characterized by enlarged ventricular dimensions, impaired cardiac function, heart failure and high risk of death.
    [Show full text]
  • Figure S1. DMD Module Network. the Network Is Formed by 260 Genes from Disgenet and 1101 Interactions from STRING. Red Nodes Are the Five Seed Candidate Genes
    Figure S1. DMD module network. The network is formed by 260 genes from DisGeNET and 1101 interactions from STRING. Red nodes are the five seed candidate genes. Figure S2. DMD module network is more connected than a random module of the same size. It is shown the distribution of the largest connected component of 10.000 random modules of the same size of the DMD module network. The green line (x=260) represents the DMD largest connected component, obtaining a z-score=8.9. Figure S3. Shared genes between BMD and DMD signature. A) A meta-analysis of three microarray datasets (GSE3307, GSE13608 and GSE109178) was performed for the identification of differentially expressed genes (DEGs) in BMD muscle biopsies as compared to normal muscle biopsies. Briefly, the GSE13608 dataset included 6 samples of skeletal muscle biopsy from healthy people and 5 samples from BMD patients. Biopsies were taken from either biceps brachii, triceps brachii or deltoid. The GSE3307 dataset included 17 samples of skeletal muscle biopsy from healthy people and 10 samples from BMD patients. The GSE109178 dataset included 14 samples of controls and 11 samples from BMD patients. For both GSE3307 and GSE10917 datasets, biopsies were taken at the time of diagnosis and from the vastus lateralis. For the meta-analysis of GSE13608, GSE3307 and GSE109178, a random effects model of effect size measure was used to integrate gene expression patterns from the two datasets. Genes with an adjusted p value (FDR) < 0.05 and an │effect size│>2 were identified as DEGs and selected for further analysis. A significant number of DEGs (p<0.001) were in common with the DMD signature genes (blue nodes), as determined by a hypergeometric test assessing the significance of the overlap between the BMD DEGs and the number of DMD signature genes B) MCODE analysis of the overlapping genes between BMD DEGs and DMD signature genes.
    [Show full text]
  • Novel Missense Mutation in PTPN22 in a Chinese Pedigree With
    Gong et al. BMC Endocrine Disorders (2018) 18:76 https://doi.org/10.1186/s12902-018-0305-8 RESEARCHARTICLE Open Access Novel missense mutation in PTPN22 in a Chinese pedigree with Hashimoto’s thyroiditis Licheng Gong1†, Beihong Liu2,3†, Jing Wang4, Hong Pan3, Anhui Qi2,3, Siyang Zhang2,3, Jinyi Wu1, Ping Yang1* and Binbin Wang3,4,5* Abstract Background: Hashimoto’s thyroiditis is a complex autoimmune thyroid disease, the onset of which is associated with environmental exposures and specific susceptibility genes. Its incidence in females is higher than its incidence in males. Thus far, although some susceptibility loci have been elaborated, including PTPN22, FOXP3, and CD25, the aetiology and pathogenesis of Hashimoto’s thyroiditis remains unclear. Methods: Four affected members from a Chinese family with Hashimoto’s thyroiditis were selected for whole-exome sequencing. Missense, nonsense, frameshift, or splicing-site variants shared by all affected members were identified after frequency filtering against public and internal exome databases. Segregation analysis was performed by Sanger sequencing among all members with available DNA. Results: We identified a missense mutation in PTPN22 (NM_015967.5; c. 77A > G; p.Asn26Ser) using whole-exome sequencing. PTPN22 is a known susceptibility gene associated with increased risks of multiple autoimmune diseases. Cosegregation analysis confirmed that all patients in this family, all of whom were female, carried the mutation. All public and private databases showed that the missense mutation was extremely rare. Conclusions: We found a missense mutation in PTPN22 in a Chinese HT pedigree using whole-exome sequencing. Our study, for the first time, linked a rare variant of PTPN22 to Hashimoto’s thyroiditis, providing further evidence of the disease-causing or susceptibility role of PTPN22 in autoimmune thyroid disease.
    [Show full text]
  • A Computational Approach for Defining a Signature of Β-Cell Golgi Stress in Diabetes Mellitus
    Page 1 of 781 Diabetes A Computational Approach for Defining a Signature of β-Cell Golgi Stress in Diabetes Mellitus Robert N. Bone1,6,7, Olufunmilola Oyebamiji2, Sayali Talware2, Sharmila Selvaraj2, Preethi Krishnan3,6, Farooq Syed1,6,7, Huanmei Wu2, Carmella Evans-Molina 1,3,4,5,6,7,8* Departments of 1Pediatrics, 3Medicine, 4Anatomy, Cell Biology & Physiology, 5Biochemistry & Molecular Biology, the 6Center for Diabetes & Metabolic Diseases, and the 7Herman B. Wells Center for Pediatric Research, Indiana University School of Medicine, Indianapolis, IN 46202; 2Department of BioHealth Informatics, Indiana University-Purdue University Indianapolis, Indianapolis, IN, 46202; 8Roudebush VA Medical Center, Indianapolis, IN 46202. *Corresponding Author(s): Carmella Evans-Molina, MD, PhD ([email protected]) Indiana University School of Medicine, 635 Barnhill Drive, MS 2031A, Indianapolis, IN 46202, Telephone: (317) 274-4145, Fax (317) 274-4107 Running Title: Golgi Stress Response in Diabetes Word Count: 4358 Number of Figures: 6 Keywords: Golgi apparatus stress, Islets, β cell, Type 1 diabetes, Type 2 diabetes 1 Diabetes Publish Ahead of Print, published online August 20, 2020 Diabetes Page 2 of 781 ABSTRACT The Golgi apparatus (GA) is an important site of insulin processing and granule maturation, but whether GA organelle dysfunction and GA stress are present in the diabetic β-cell has not been tested. We utilized an informatics-based approach to develop a transcriptional signature of β-cell GA stress using existing RNA sequencing and microarray datasets generated using human islets from donors with diabetes and islets where type 1(T1D) and type 2 diabetes (T2D) had been modeled ex vivo. To narrow our results to GA-specific genes, we applied a filter set of 1,030 genes accepted as GA associated.
    [Show full text]
  • Protein UBE2R2
    Catalogue # Aliquot Size U235-30H-20 20 µg U235-30H-50 50 µg UBE2R2 (UBC3B) Protein Recombinant protein expressed in E.coli cells Catalog # U235-30H Lot # J617 -4 Product Description Purity Recombinant human UBE2R2 (UBC3B) (2-end) was expressed in E. coli cells using an N-terminal His tag. The gene accession number is NM_017811 . The purity of UBE2R2 (UBC3B) was Gene Aliases determined to be >90% by densitometry. CDC34B; E2-CDC34B; UBC3B Approx. MW 32 kDa . Formulation Recombinant protein stored in 50mM sodium phosphate, pH 7.0, 300mM NaCl, 150mM imidazole, 0.1mM PMSF, 0.25mM DTT, 25% glycerol. Storage and Stability o Store product at –70 C. For optimal storage, aliquot target into smaller quantities after centrifugation and store at recommended temperature. For most favorable performance, avoid repeated handling and multiple freeze/thaw cycles. Scientific Background UBE2R2 (UBC3B) or ubiquitin-conjugating enzyme E2R 2 encodes a protein similar to the E2 ubiquitin conjugating enzyme UBC3/CDC34. CK2-dependent phosphorylation of this ubiquitin-conjugating enzyme functions by regulating beta-TrCP substrate recognition and induces UBE2R2 (UBC3B) Protein its interaction with beta-TrCP therby enhancing beta- Recombinant protein expressed in E. coli cells catenin degradation. CK2-dependent phosphorylation of CDC34 and UBC3B functions by regulating BTRC substrate Catalog Number U235-30H recognition (1). UBE2R2 complements a yeast cdc34 Specific Lot Number J617-4 temperature-sensitive mutant. Deletion and site-directed Purity >90% mutagenesis demonstrated that CK2 phosphorylated Concentration 0.1 µg/ µl Stability 1yr at –70 oC from date of shipment UBE2R2 in the C-terminal domain at serine-233; Storage & Shipping Store product at –70 oC.
    [Show full text]
  • Uncovering Ubiquitin and Ubiquitin-Like Signaling Networks Alfred C
    REVIEW pubs.acs.org/CR Uncovering Ubiquitin and Ubiquitin-like Signaling Networks Alfred C. O. Vertegaal* Department of Molecular Cell Biology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands CONTENTS 8. Crosstalk between Post-Translational Modifications 7934 1. Introduction 7923 8.1. Crosstalk between Phosphorylation and 1.1. Ubiquitin and Ubiquitin-like Proteins 7924 Ubiquitylation 7934 1.2. Quantitative Proteomics 7924 8.2. Phosphorylation-Dependent SUMOylation 7935 8.3. Competition between Different Lysine 1.3. Setting the Scenery: Mass Spectrometry Modifications 7935 Based Investigation of Phosphorylation 8.4. Crosstalk between SUMOylation and the and Acetylation 7925 UbiquitinÀProteasome System 7935 2. Ubiquitin and Ubiquitin-like Protein Purification 9. Conclusions and Future Perspectives 7935 Approaches 7925 Author Information 7935 2.1. Epitope-Tagged Ubiquitin and Ubiquitin-like Biography 7935 Proteins 7925 Acknowledgment 7936 2.2. Traps Based on Ubiquitin- and Ubiquitin-like References 7936 Binding Domains 7926 2.3. Antibody-Based Purification of Ubiquitin and Ubiquitin-like Proteins 7926 1. INTRODUCTION 2.4. Challenges and Pitfalls 7926 Proteomes are significantly more complex than genomes 2.5. Summary 7926 and transcriptomes due to protein processing and extensive 3. Ubiquitin Proteomics 7927 post-translational modification (PTM) of proteins. Hundreds ff fi 3.1. Proteomic Studies Employing Tagged of di erent modi cations exist. Release 66 of the RESID database1 (http://www.ebi.ac.uk/RESID/) contains 559 dif- Ubiquitin 7927 ferent modifications, including small chemical modifications 3.2. Ubiquitin Binding Domains 7927 such as phosphorylation, acetylation, and methylation and mod- 3.3. Anti-Ubiquitin Antibodies 7927 ification by small proteins, including ubiquitin and ubiquitin- 3.4.
    [Show full text]
  • Α Are Regulated by Heat Shock Protein 90
    The Levels of Retinoic Acid-Inducible Gene I Are Regulated by Heat Shock Protein 90- α Tomoh Matsumiya, Tadaatsu Imaizumi, Hidemi Yoshida, Kei Satoh, Matthew K. Topham and Diana M. Stafforini This information is current as of October 2, 2021. J Immunol 2009; 182:2717-2725; ; doi: 10.4049/jimmunol.0802933 http://www.jimmunol.org/content/182/5/2717 Downloaded from References This article cites 44 articles, 19 of which you can access for free at: http://www.jimmunol.org/content/182/5/2717.full#ref-list-1 Why The JI? Submit online. http://www.jimmunol.org/ • Rapid Reviews! 30 days* from submission to initial decision • No Triage! Every submission reviewed by practicing scientists • Fast Publication! 4 weeks from acceptance to publication *average by guest on October 2, 2021 Subscription Information about subscribing to The Journal of Immunology is online at: http://jimmunol.org/subscription Permissions Submit copyright permission requests at: http://www.aai.org/About/Publications/JI/copyright.html Email Alerts Receive free email-alerts when new articles cite this article. Sign up at: http://jimmunol.org/alerts The Journal of Immunology is published twice each month by The American Association of Immunologists, Inc., 1451 Rockville Pike, Suite 650, Rockville, MD 20852 Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved. Print ISSN: 0022-1767 Online ISSN: 1550-6606. The Journal of Immunology The Levels of Retinoic Acid-Inducible Gene I Are Regulated by Heat Shock Protein 90-␣1 Tomoh Matsumiya,*‡ Tadaatsu Imaizumi,‡ Hidemi Yoshida,‡ Kei Satoh,‡ Matthew K. Topham,*† and Diana M. Stafforini2*† Retinoic acid-inducible gene I (RIG-I) is an intracellular pattern recognition receptor that plays important roles during innate immune responses to viral dsRNAs.
    [Show full text]
  • Contributions of the Renin Angiotensin System to Fear Memory and Fear Conditioned Cardiovascular Responses
    Contributions of the Renin Angiotensin System to Fear Memory and Fear Conditioned Cardiovascular Responses by Adam Swiercz B.S. in Biology, May 2006, The George Washington University M.P.S. in Molecular Biotechnology, May 2009, The George Washington University M.S. in Physiology, May 2011, Georgetown University A Dissertation submitted to The Faculty of The Columbian College of Arts & Sciences of The George Washington University in partial fulfillment of the requirements for the degree of Doctor of Philosophy January 10, 2020 Dissertation co-directed by Paul J. Marvar Associate Professor of Pharmacology and Physiology and David Mendelowitz Professor of Pharmacology & Physiology The Columbian College of Arts and Sciences of The George Washington University certifies that Adam Swiercz has passed the Final Examination for the degree of Doctor of Philosophy as of October 2nd, 2019. This is the final and approved form of the dissertation. Contributions of the Renin Angiotensin System to Fear Memory and Fear Conditioned Cardiovascular Responses Adam Swiercz Dissertation Research Committee: Paul J. Marvar, Associate Professor of Pharmacology & Physiology, Dissertation Co-Director David Mendelowitz, Professor of Pharmacology & Physiology, Dissertation Co-Director Abigail Polter, Assistant Professor of Pharmacology & Physiology, Committee Member Colin Young, Assistant Professor of Pharmacology & Physiology, Committee Member ii © Copyright 2020 by Adam Swiercz All rights reserved iii Acknowledgements I would like to thank and acknowledge Dr. Paul Marvar, whose mentorship has made this dissertation possible. It has been a pleasure working in your lab, and I am truly grateful for your support and encouragement throughout the years. Thanks to the current and former members of the Marvar lab who have made my time at GW a rewarding and enjoyable experience.
    [Show full text]
  • Product Information
    Product information Monoclonal anti-human UBE2L6 antibody (clone K1H3) Mouse IgG2b, Cat. No. IBAUB0907 Immunogen: Recombinant human UBE2L6 (1-152aa) purified from E. coli NCBI Accession No.: NP_004214 Isotype: Mouse IgG2b heavy chain and light chain Clone: Anti-human UBE2L6 mAb, clone K1H3, is derived from hybridization of mouse F0 myeloma cells with spleen cells from BALB/c mice immunized with a recombinant human UBE2L6 protein. Description: Ubiquitin-conjugating enzyme E2L6 (UBE2L6), also known as UbcH8, is a member of the E2 ubiquitin-conjugating enzyme family. The modification of proteins with ubiquitin is an important cellular mechanism for targeting abnormal or short-lived proteins for degradation. Ubiquitination of a protein substrate requires the concerted action of 3 classes of enzymes: E1 ubiquitin-activating enzymes, E2 ubiquitin- conjugating enzymes, and E3 ubiquitin protein ligases. The E2 ubiquitin-conjugating enzyme is highly similar in primary structure to the enzyme encoded by UBE2L3 gene. Concentration: 1mg/ml Form: Liquid. In Phosphate-Buffered Saline (pH 7.4) with 0.02% Sodium Azide, 10% Glycerol. Storage: Can be stored at +4°C. For long term storage, aliquot and store at -20°C. Avoid repeated freezing and thawing cycles. Usage: The antibody has been tested by ELISA, Western blot analysis, Flow cytometry and ICC/IF immunohistochemistry to assure specificity and reactivity. Since application varies, however, each investigation should be titrated by the reagent to obtain optimal results. Application: ELISA, WB, IHC, Flow cytometry, ICC/IF For research use only. This product is not intended or approved for human, diagnostics or veterinary use. Manufactured for: Immuno-Biological Laboratories, Inc.
    [Show full text]
  • Symbiotic Adaptations in the Fungal Cultivar of Leaf-Cutting Ants
    ARTICLE Received 15 Apr 2014 | Accepted 24 Oct 2014 | Published 1 Dec 2014 DOI: 10.1038/ncomms6675 Symbiotic adaptations in the fungal cultivar of leaf-cutting ants Henrik H. De Fine Licht1,w, Jacobus J. Boomsma2 & Anders Tunlid1 Centuries of artificial selection have dramatically improved the yield of human agriculture; however, strong directional selection also occurs in natural symbiotic interactions. Fungus- growing attine ants cultivate basidiomycete fungi for food. One cultivar lineage has evolved inflated hyphal tips (gongylidia) that grow in bundles called staphylae, to specifically feed the ants. Here we show extensive regulation and molecular signals of adaptive evolution in gene trancripts associated with gongylidia biosynthesis, morphogenesis and enzymatic plant cell wall degradation in the leaf-cutting ant cultivar Leucoagaricus gongylophorus. Comparative analysis of staphylae growth morphology and transcriptome-wide expressional and nucleotide divergence indicate that gongylidia provide leaf-cutting ants with essential amino acids and plant-degrading enzymes, and that they may have done so for 20–25 million years without much evolutionary change. These molecular traits and signatures of selection imply that staphylae are highly advanced coevolutionary organs that play pivotal roles in the mutualism between leaf-cutting ants and their fungal cultivars. 1 Microbial Ecology Group, Department of Biology, Lund University, Ecology Building, SE-223 62 Lund, Sweden. 2 Centre for Social Evolution, Department of Biology, University of Copenhagen, Universitetsparken 15, DK-2100 Copenhagen, Denmark. w Present Address: Section for Organismal Biology, Department of Plant and Environmental Sciences, University of Copenhagen, Thorvaldsensvej 40, DK-1871 Frederiksberg, Denmark. Correspondence and requests for materials should be addressed to H.H.D.F.L.
    [Show full text]